Natrium-Hydrogen-Carbonicum Pharmamagist (Sodium Hydrogen Carbonate)

Sodium Hydrogen Carbonate is employed as an alkalinising and buffering agent in several clinical contexts.

• Metabolic acidosis: helps correct systemic acid‑base imbalance by increasing plasma bicarbonate levels.
• Hyperkalemia: promotes intracellular shift of potassium, aiding in temporary reduction of serum potassium.
• Urinary alkalinisation: facilitates excretion of certain drugs and toxins by raising urinary pH.
• Injectable solution preparation: serves as a solvent and pH stabiliser for various IV and subcutaneous formulations.

• After administration, Sodium Hydrogen Carbonate dissociates into sodium and bicarbonate ions. The bicarbonate acts as a physiological buffer, combining with hydrogen ions to form carbonic acid, which is then converted to CO₂ and water, thereby raising extracellular pH. This alkalinising effect modifies electrolyte distribution and enhances renal excretion of acidic compounds.

Sodium Hydrogen Carbonate may cause a range of adverse reactions depending on dose and patient condition.

Common Side Effects

• Metabolic alkalosis: elevated blood pH leading to dizziness or fatigue.
• Hypernatremia: increased serum sodium causing thirst or edema.
• Hypokalemia: lowered potassium levels resulting in muscle weakness.
• Fluid overload: excess volume leading to peripheral edema.
• Nausea or mild gastrointestinal discomfort.

Serious or Rare Side Effects

• Severe metabolic alkalosis with respiratory depression.
• Paradoxical intracellular acidosis.
• Cardiac arrhythmias due to electrolyte shifts.
• Pulmonary edema in patients with compromised cardiac function.
• Seizures secondary to extreme alkalosis.

When using Sodium Hydrogen Carbonate, clinicians should observe several safety measures.

• Assess acid‑base status: verify baseline pH and bicarbonate before initiation.
• Monitor electrolytes: regularly check serum sodium, potassium, and chloride.
• Adjust dose in renal impairment: reduced clearance may increase risk of alkalosis.
• Use cautiously in heart failure or hypertension: fluid and sodium load can exacerbate conditions.
• Avoid in severe hypernatremia: further sodium increase may be harmful.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Sodium Hydrogen Carbonate can influence the pharmacokinetics or safety of several agents.

Major Interactions (Avoid)

• Concomitant use with potassium‑sparing diuretics: risk of hyperkalemia.
• Co‑administration with calcium carbonate: may cause excessive alkalosis.
• Interaction with certain antibiotics (e.g., tetracyclines): reduced absorption due to increased gastric pH.

Moderate Interactions (Monitor Closely)

• Use with anticoagulants (e.g., warfarin): altered plasma protein binding may affect INR.
• Combination with loop diuretics: enhanced loss of potassium and magnesium.
• Concurrent administration of insulin: may potentiate intracellular potassium shift.